一项教育干预措施,以促进中枢神经系统活性降低痴呆症:试点研究
Noah M Barnett1, Sarah E Vordenberg2, H Myra Kim3,4
1University of Michigan Medical School, Ann Arbor, MI, USA.
Drugs & aging
|January 20, 2025
概括
一本邮寄的小册子并没有促使人们对生活在痴呆症 (PLWD) 中枢神经系统 (CNS) 活跃的多药学. 干预没有显示药物使用或多药物的显著减少.
科学领域:
- 老年医学 老年医学
- 临床药理学 临床药理学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 中枢神经系统 (CNS) 活性多药在患有痴呆症 (PLWD) 的人群中很常见,并具有重大风险.
- 在PLWD中识别和解决多药学是一个关键的临床挑战.
研究的目的:
- 评估以患者为中心的干预措施的可行性和初步有效性,以促进抑郁症谈话.
- 评价一本邮寄的教育小册子,作为一个激发关于PLWD中中枢神经系统活性多药学的讨论的工具.
主要方法:
- 在初级保健诊所进行了一项试点随机对照试验.
- 接受中枢神经系统活性多药物的PLWD被随机分配到接受教育宣传册或通常的护理.
- 电子健康记录和临床医生采访被用来评估干预结果.
主要成果:
- 在传递小册子后,PLWD和临床医生之间没有发生过描述抑郁症的对话的记录证据.
- 在中枢神经系统活性药物的数量,总标准化每日剂量或多药的流行率方面,没有观察到群体之间的显著差异.
- 临床医生指出,时间限制和缺乏更安全的替代品是抑郁症的障碍.
结论:
- 直接发送给患者的教育小册子不是一个可行的策略,可以启动对PLWD中中枢神经系统活性多药的抑郁症谈话.
- 需要进一步的研究来开发有效的干预措施,以减少这种脆弱人群中的多药性.
更多相关视频
12:18A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
7.5K
07:58Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression
Published on: February 24, 2023
450
相关概念视频
01:22Alzheimer's Disease: Treatment
160
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
160
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
95
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
95
01:14CNS Depressants: Barbiturates and Benzodiazepines
217
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
217
01:28Drug Therapy
37
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
37
01:27CNS Depressants: Alcohol and Nicotine
170
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
170
01:25Antidepressant Drugs: Overview
354
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
354